148 related articles for article (PubMed ID: 32662248)
1. Neurocognitive development and capabilities in boys with 49,XXXXY syndrome.
Gropman AL; Porter GF; Lasutschinkow PC; Sadeghin T; Tipton ES; Powell S; Samango-Sprouse CA
Am J Med Genet A; 2021 Dec; 185(12):3541-3546. PubMed ID: 32662248
[TBL] [Abstract][Full Text] [Related]
2. 49,XXXXY syndrome: A study of neurological function in this uncommon X and Y chromosomal disorder.
Samango-Sprouse C; Lasutschinkow PC; Mitchell F; Porter GF; Hendrie P; Powell S; Sadeghin T; Gropman A
Am J Med Genet A; 2021 Dec; 185(12):3557-3566. PubMed ID: 32656941
[TBL] [Abstract][Full Text] [Related]
3. Clinical variability and novel neurodevelopmental findings in 49, XXXXY syndrome.
Gropman AL; Rogol A; Fennoy I; Sadeghin T; Sinn S; Jameson R; Mitchell F; Clabaugh J; Lutz-Armstrong M; Samango-Sprouse CA
Am J Med Genet A; 2010 Jun; 152A(6):1523-30. PubMed ID: 20503329
[TBL] [Abstract][Full Text] [Related]
4. Speech and language development in children with 49,XXXXY syndrome.
Samango-Sprouse CA; Lasutschinkow PC; McLeod M; Porter GF; Powell S; St Laurent J; Sadeghin T; Gropman AL
Am J Med Genet A; 2021 Dec; 185(12):3567-3575. PubMed ID: 32725750
[TBL] [Abstract][Full Text] [Related]
5. Evidence of intrauterine growth restriction and growth hormone deficiency in 49,XXXXY syndrome.
Counts DR; Yu C; Lasutschinkow PC; Sadeghin T; Gropman A; Samango-Sprouse CA
Am J Med Genet A; 2021 Dec; 185(12):3547-3553. PubMed ID: 32618131
[TBL] [Abstract][Full Text] [Related]
6. Behavioral phenotype of 49,XXXXY syndrome: Presence of anxiety-related symptoms and intact social awareness.
Lasutschinkow PC; Gropman AL; Porter GF; Sadeghin T; Samango-Sprouse CA
Am J Med Genet A; 2020 May; 182(5):974-986. PubMed ID: 32083381
[TBL] [Abstract][Full Text] [Related]
7. Klinefelter syndrome and other sex chromosomal aneuploidies.
Visootsak J; Graham JM
Orphanet J Rare Dis; 2006 Oct; 1():42. PubMed ID: 17062147
[TBL] [Abstract][Full Text] [Related]
8. An extra X or Y chromosome: contrasting the cognitive and motor phenotypes in childhood in boys with 47,XYY syndrome or 47,XXY Klinefelter syndrome.
Ross JL; Zeger MP; Kushner H; Zinn AR; Roeltgen DP
Dev Disabil Res Rev; 2009; 15(4):309-17. PubMed ID: 20014371
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive variance and neurological underpinnings of the X and Y chromosomal variations.
Gropman A; Samango-Sprouse CA
Am J Med Genet C Semin Med Genet; 2013 Feb; 163C(1):35-43. PubMed ID: 23335129
[TBL] [Abstract][Full Text] [Related]
10. Musculoskeletal abnormalities in a large international cohort of boys with 49,XXXXY.
Tosi L; Mitchell F; Porter GF; Ruland L; Gropman A; Lasutschinkow PC; Tran SL; Rajah EN; Gillies AP; Hendrie P; Peret R; Sadeghin T; Samango-Sprouse CA
Am J Med Genet A; 2021 Dec; 185(12):3531-3540. PubMed ID: 32243688
[TBL] [Abstract][Full Text] [Related]
11. Behavioral phenotype of sex chromosome aneuploidies: 48,XXYY, 48,XXXY, and 49,XXXXY.
Visootsak J; Rosner B; Dykens E; Tartaglia N; Graham JM
Am J Med Genet A; 2007 Jun; 143A(11):1198-203. PubMed ID: 17497714
[TBL] [Abstract][Full Text] [Related]
12. Neurodevelopmental outcome of prenatally diagnosed boys with 47,XXY (Klinefelter syndrome) and the potential influence of early hormonal therapy.
Samango-Sprouse CA; Tran SL; Lasutschinkow PC; Sadeghin T; Powell S; Mitchell FL; Gropman A
Am J Med Genet A; 2020 Aug; 182(8):1881-1889. PubMed ID: 32220052
[TBL] [Abstract][Full Text] [Related]
13. Social function in multiple X and Y chromosome disorders: XXY, XYY, XXYY, XXXY.
Visootsak J; Graham JM
Dev Disabil Res Rev; 2009; 15(4):328-32. PubMed ID: 20014367
[TBL] [Abstract][Full Text] [Related]
14. The effect of early hormonal treatment (EHT) on expressive and receptive language capabilities in boys with 47,XXY (Klinefelter syndrome) during infancy and early childhood.
Samango-Sprouse C; Brooks MR; Lasutchinkow P; Sadeghin T; Powell S; Hamzik MP; Song S; Gropman AL
Genet Med; 2021 Jun; 23(6):1017-1022. PubMed ID: 33627828
[TBL] [Abstract][Full Text] [Related]
15. Effects of short-course androgen therapy on the neurodevelopmental profile of infants and children with 49,XXXXY syndrome.
Samango-Sprouse CA; Gropman AL; Sadeghin T; Kingery M; Lutz-Armstrong M; Rogol AD
Acta Paediatr; 2011 Jun; 100(6):861-5. PubMed ID: 21362043
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation and behavioral dysfunction in males with 47,XXY and 49,XXXXY: a pilot study.
Lee RS; Song SQ; Garrison-Desany HM; Carey JL; Lasutschinkow P; Zabel A; Bressler J; Gropman A; Samango-Sprouse C
Clin Epigenetics; 2021 Jul; 13(1):136. PubMed ID: 34210361
[TBL] [Abstract][Full Text] [Related]
17. Expanding the phenotypic profile of boys with 47, XXY: the impact of familial learning disabilities.
Samango-Sprouse CA; Stapleton EJ; Mitchell FL; Sadeghin T; Donahue TP; Gropman AL
Am J Med Genet A; 2014 Jun; 164A(6):1464-9. PubMed ID: 24715716
[TBL] [Abstract][Full Text] [Related]
18. Introduction: Comprehensive investigation into an international cohort of boys with 49,XXXXY.
Samango-Sprouse CA; Gropman AL
Am J Med Genet A; 2021 Dec; 185(12):3554-3556. PubMed ID: 32656873
[No Abstract] [Full Text] [Related]
19. Clinical, Cognitive and Neurodevelopmental Profile in Tetrasomies and Pentasomies: A Systematic Review.
Ricciardi G; Cammisa L; Bove R; Picchiotti G; Spaziani M; Isidori AM; Aceti F; Giacchetti N; Romani M; Sogos C
Children (Basel); 2022 Nov; 9(11):. PubMed ID: 36360447
[No Abstract] [Full Text] [Related]
20. The behavioral profile of 49,XXXXY and the potential impact of testosterone replacement therapy.
Samango-Sprouse CA; Hamzik MP; Gropman E; Brooks MR; Powell S; Taylor AM; Sadeghin T; Gropman AL
Genet Med; 2023 Jul; 25(7):100847. PubMed ID: 37061875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
